Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Reed

Showing results (11-20 of 263) with videos related to

Pageof 27
Sort By:
Expert Review of Vaccines|July 27, 2013
Adjuvants containing natural and synthetic Toll-like receptor 4 ligandsGregory C Ireton, Steven G Reed
Infection and Immunity|July 16, 2008
Immunological dominance of Trypanosoma cruzi tandem repeat proteinsYasuyuki Goto, Darrick Carter, Steven G Reed
Current Topics in Microbiology and Immunology|July 26, 2018
AdjuvantsDarrick Carter, Malcolm S Duthie, Steven G Reed
Current Opinion in Immunology|October 10, 2020
New horizons in adjuvants for vaccine developmentSteven G Reed, Mark Tomai, Michael J Gale
Future Microbiology|October 13, 2018
Second coming: the re-emergence and modernization of immunotherapy by vaccines as a component of leprosy controlMalcolm S Duthie, Corey Casper, Steven G Reed
Memorias Do Instituto Oswaldo Cruz|January 4, 2013
The potential for vaccination in leprosy elimination: new tools for targeted interventionsMalcolm S Duthie, Paul Saunderson, Steven G Reed
Infection and Immunity|November 8, 2006
Bioinformatic identification of tandem repeat antigens of the Leishmania donovani complexYasuyuki Goto, Rhea N Coler, Steven G Reed
Expert Review of Vaccines|August 6, 2003
Development of a leishmaniasis vaccine: the importance of MPLSteven G Reed, Rhea N Coler, Antonio Campos-Neto
Human Vaccines|November 4, 2011
Advances and hurdles on the way toward a leprosy vaccineMalcolm S Duthie, Thomas P Gillis, Steven G Reed
Nature Medicine|December 7, 2013
Key roles of adjuvants in modern vaccinesSteven G Reed, Mark T Orr, Christopher B Fox
Pageof 27

Showing results (11-20 of 263) with videos related to

Sort By:
Pageof 27
Expert Review of Vaccines|July 27, 2013
Adjuvants containing natural and synthetic Toll-like receptor 4 ligandsGregory C Ireton, Steven G Reed
Infection and Immunity|July 16, 2008
Immunological dominance of Trypanosoma cruzi tandem repeat proteinsYasuyuki Goto, Darrick Carter, Steven G Reed
Current Topics in Microbiology and Immunology|July 26, 2018
AdjuvantsDarrick Carter, Malcolm S Duthie, Steven G Reed
Current Opinion in Immunology|October 10, 2020
New horizons in adjuvants for vaccine developmentSteven G Reed, Mark Tomai, Michael J Gale
Future Microbiology|October 13, 2018
Second coming: the re-emergence and modernization of immunotherapy by vaccines as a component of leprosy controlMalcolm S Duthie, Corey Casper, Steven G Reed
Memorias Do Instituto Oswaldo Cruz|January 4, 2013
The potential for vaccination in leprosy elimination: new tools for targeted interventionsMalcolm S Duthie, Paul Saunderson, Steven G Reed
Infection and Immunity|November 8, 2006
Bioinformatic identification of tandem repeat antigens of the Leishmania donovani complexYasuyuki Goto, Rhea N Coler, Steven G Reed
Expert Review of Vaccines|August 6, 2003
Development of a leishmaniasis vaccine: the importance of MPLSteven G Reed, Rhea N Coler, Antonio Campos-Neto
Human Vaccines|November 4, 2011
Advances and hurdles on the way toward a leprosy vaccineMalcolm S Duthie, Thomas P Gillis, Steven G Reed
Nature Medicine|December 7, 2013
Key roles of adjuvants in modern vaccinesSteven G Reed, Mark T Orr, Christopher B Fox
Pageof 27